Meritain Health policies
Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
10 policies name 62270, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 1073-Eladocagene Exuparvovec-tneq (Kebilidi) | 1073 · Commercial | 10 | Original policy ↗ |
| 0996-Aducanumab-avwa (Aduhelm) | 0996 · Commercial | 20 | Original policy ↗ |
| 1026-Lecanemab-irmb (Leqembi) | 1026 · Commercial | 21 | Original policy ↗ |
| Donanemab-azbt (Kisunla) | 1066 · Commercial | 21 | Original policy ↗ |
| 0915-Nusinersen (Spinraza) | 0915 · Commercial | 30 | Original policy ↗ |
| 1039-Venous Stenting for the Treatment of Idiopathic Intracranial Hypertension | 1039 · Commercial | 53 | Original policy ↗ |
| Alzheimer's Disease Tests | 0349 · Commercial | 60 | Original policy ↗ |
| 0953-Onasemnogene Abeparvovec (Zolgensma and Itvisma) | 0953 · Commercial | 62 | Original policy ↗ |
| Parenteral Immunoglobulins | 0206 · Commercial | 107 | Original policy ↗ |
| 0952-Ultrasound Guidance - Selected Indications | 0952 · Commercial | 180 | Original policy ↗ |